Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jao Yiu Sung

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Chinese Clinical Oncology|April 6, 2015
Colorectal cancer screening: are stool and blood based tests good enough?Chung-Wah Wu, Joseph Jao-Yiu Sung
Current Opinion in Infectious Diseases|September 9, 2005
Advances in chronic viral hepatitisAlex Yui Hui, Joseph Jao-Yiu Sung
Current Opinion in Molecular Therapeutics|April 14, 2006
HBV-ISS (Dynavax)Joseph Jao-Yiu Sung, Henry Lik-Yuen
Current Opinion in Infectious Diseases|August 21, 2012
Diagnosis and personalized management of hepatitis B including significance of genotypesVincent Wai-Sun Wong, Joseph Jao-Yiu Sung
Seminars in Liver Disease|May 5, 2006
Hepatocellular carcinoma and hepatitis B virusHenry Lik-Yuen Chan, Joseph Jao-Yiu Sung
The Journal of Antimicrobial Chemotherapy|May 27, 2009
Antiviral therapy for chronic hepatitis B: are we doing any good to patients?Vincent Wai-Sun Wong, Joseph Jao-Yiu Sung
Gut Microbes|January 13, 2021
Gut microbiota: impacts on gastrointestinal cancer immunotherapyHarry Cheuk Hay Lau, Joseph Jao-Yiu Sung, Jun Yu
Journal of Virology|June 18, 2011
In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenumMartin Chi-Wai Chan, Wing-Shan Ho, Joseph Jao-Yiu Sung
Cell Research|October 11, 2005
p53-independent pRB degradation contributes to a drug-induced apoptosis in AGS cellsYan Jin, Wai Keung Leung, Joseph Jao-Yiu Sung, et al.
Biochemical and Biophysical Research Communications|April 26, 2008
Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signalingWilliam Ka Kei Wu, Joseph Jao Yiu Sung, Le Yu, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Chinese Clinical Oncology|April 6, 2015
Colorectal cancer screening: are stool and blood based tests good enough?Chung-Wah Wu, Joseph Jao-Yiu Sung
Current Opinion in Infectious Diseases|September 9, 2005
Advances in chronic viral hepatitisAlex Yui Hui, Joseph Jao-Yiu Sung
Current Opinion in Molecular Therapeutics|April 14, 2006
HBV-ISS (Dynavax)Joseph Jao-Yiu Sung, Henry Lik-Yuen
Current Opinion in Infectious Diseases|August 21, 2012
Diagnosis and personalized management of hepatitis B including significance of genotypesVincent Wai-Sun Wong, Joseph Jao-Yiu Sung
Seminars in Liver Disease|May 5, 2006
Hepatocellular carcinoma and hepatitis B virusHenry Lik-Yuen Chan, Joseph Jao-Yiu Sung
The Journal of Antimicrobial Chemotherapy|May 27, 2009
Antiviral therapy for chronic hepatitis B: are we doing any good to patients?Vincent Wai-Sun Wong, Joseph Jao-Yiu Sung
Gut Microbes|January 13, 2021
Gut microbiota: impacts on gastrointestinal cancer immunotherapyHarry Cheuk Hay Lau, Joseph Jao-Yiu Sung, Jun Yu
Journal of Virology|June 18, 2011
In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenumMartin Chi-Wai Chan, Wing-Shan Ho, Joseph Jao-Yiu Sung
Cell Research|October 11, 2005
p53-independent pRB degradation contributes to a drug-induced apoptosis in AGS cellsYan Jin, Wai Keung Leung, Joseph Jao-Yiu Sung, et al.
Biochemical and Biophysical Research Communications|April 26, 2008
Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signalingWilliam Ka Kei Wu, Joseph Jao Yiu Sung, Le Yu, et al.
Pageof 14